DelMar Pharmaceuticals Inc (NASDAQ:DMPI)

0.9825
Delayed Data
As of May 21
 -0.0075 / -0.76%
Today’s Change
0.78
Today|||52-Week Range
2.84
-9.86%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-8.3M-4.3M-8.9M-8.1M
 
 
 
 
 
Depreciation0.00--10.3K16.7K
 
 
 
Total Other Cash Flow3.8M-31.9K3.8M524.4K
 
 
 
 
 
Funds From Operations-4.5M-4.4M-5.0M-7.5M
 
 
 
 
 
Funds From/For Other Operating Expenses983.6K-526.5K117.3K478.4K
 
 
 
 
 
Net Cash Flow - Operating Activities-5.5M-3.9M-5.1M-8.0M
 
 
 
 
 
 
InvestingNet Cash Flow Investing0.000.00-16.8K-21.0K
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.00-550.1K0.000.00
 
 
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale9.6M1.4M9.6M8.5M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.00-6.3K-8.4K-8.4K
 
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing9.6M847.8K9.6M8.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash4.1M-3.0M4.4M428.8K